Rhenman & Partners Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-35,000
| Closed | -$5.92M | – | 98 |
|
|
2023
Q3 | $5.92M | Hold |
35,000
| – | – | 0.64% | 45 |
|
|
2023
Q2 | $7.59M | Sell |
35,000
-2,000
| -5% | -$434K | 0.8% | 41 |
|
|
2023
Q1 | $6.67M | Buy |
37,000
+7,000
| +23% | +$1.26M | 0.73% | 46 |
|
|
2022
Q4 | $5.9M | Buy |
30,000
+10,000
| +50% | +$1.97M | 0.62% | 53 |
|
|
2022
Q3 | $4.39M | Buy |
+20,000
| New | +$4.39M | 0.46% | 62 |
|